SCHEMBL469581

SCHEMBL469581

CCCCC/C=C/C/C=C/CCCCCCCC(N)=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 1.00
▸ SOAT1 P35610 2/20 1.00
▸ CNR1 P21554 1/20 0.89
▸ FAAH O00519 3/20 0.89
▸ CYP3A4 P08684 2/20 0.89
▸ MEN1 O00255 1/20 0.89
▸ TP53 P04637 1/20 0.89
▸ CYP1A2 P05177 1/20 0.89
▸ CYP2C19 P33261 1/20 0.89
▸ KMT2A Q03164 1/20 0.89
▸ ALDH1A1 P00352 4/20 0.73
▸ F7 P08709 4/20 0.73
▸ F3 P13726 4/20 0.73
▸ PPARG P37231 3/20 0.73
▸ PPARD Q03181 3/20 0.73
▸ PPARA Q07869 3/20 0.73
▸ FFAR1 O14842 3/20 0.73
▸ FABP3 P05413 3/20 0.73
▸ PTGS1 P23219 2/20 0.73
▸ DUSP3 P51452 1/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL571437 1.00 KDM4E (1.00) KDM4ESOAT1CNR1FAAHCYP3A4
SCHEMBL10445407 1.00 KDM4E (1.00) KDM4ESOAT1CNR1FAAHCYP3A4
SCHEMBL10445589 1.00 KDM4E (1.00) KDM4ESOAT1CNR1FAAHCYP3A4
SCHEMBL124306 1.00 KDM4E (1.00) KDM4ESOAT1CNR1FAAHCYP3A4
SCHEMBL571436 1.00 KDM4E (1.00) KDM4ESOAT1CNR1FAAHCYP3A4
SCHEMBL7626693 1.00 KDM4E (1.00) KDM4ESOAT1CNR1FAAHCYP3A4
SCHEMBL5905645 1.00 KDM4E (1.00) KDM4ESOAT1CNR1FAAHCYP3A4
SCHEMBL18619526 1.00 KDM4E (1.00) KDM4ESOAT1CNR1FAAHCYP3A4
SCHEMBL10445415 1.00 KDM4E (1.00) KDM4ESOAT1CNR1FAAHCYP3A4
SCHEMBL10445406 1.00 KDM4E (1.00) KDM4ESOAT1CNR1FAAHCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117205174-A Nanoparticle adjuvant of co-supported anions and hydrophobic immunoadjuvant, and preparation method and application thereof 广州立得生物医药科技有限公司 2023-12-12 — — CN claimed
EP-4731602-A1 NEW CLASS OF LIPIDS FOR DELIVERING ACTIVE INGREDIENTS INTO CELLS OZ Biosciences (FR) 2026-04-29 — — EP disclosed
EP-4712979-A1 COMPOUNDS AND ADJUVANT FORMULATIONS USEFUL IN PNEUMOCOCCAL VACCINES Merck Sharp & Dohme LLC (US) 2026-03-25 — — EP disclosed
EP-4712964-A1 COMPOUNDS AND FORMULATIONS USEFUL AS VACCINE ADJUVANTS Merck Sharp & Dohme LLC (US) 2026-03-25 — — EP disclosed
CN-119296764-A Marker for detecting sensitivity of tumor radiotherapy and screening method and application thereof 福建医科大学附属协和医院 2025-01-10 — — CN disclosed
WO-2024261311-A1 NEW CLASS OF LIPIDS FOR DELIVERING ACTIVE INGREDIENTS INTO CELLS OZ BIOSCIENCES (FR) 2024-12-26 — — WO disclosed
CN-119165078-A Combined marker for detecting tumor radiotherapy sensitivity and application thereof 福建医科大学附属协和医院 2024-12-20 — — CN disclosed
WO-2024238735-A1 COMPOUNDS AND FORMULATIONS USEFUL AS VACCINE ADJUVANTS MERCK SHARP & DOHME LLC (US) 2024-11-21 — — WO disclosed
WO-2024238731-A1 COMPOUNDS AND ADJUVANT FORMULATIONS USEFUL IN PNEUMOCOCCAL VACCINES MERCK SHARP & DOHME LLC (US) 2024-11-21 — — WO disclosed
WO-2024152512-A1 LIPID COMPOUND FOR DELIVERY OF THERAPEUTIC AGENT, PREPARATION METHOD THEREFOR AND USE THEREOF 尧唐(上海)生物科技有限公司 2024-07-25 — — WO disclosed
EP-3145660-A1 NEW PRODUCT Höganäs AB (publ) (SE) 2017-03-29 — — EP disclosed
WO-2015177300-A1 NEW PRODUCT HÖGANÄS AB (PUBL) (SE) 2015-11-26 — — WO disclosed
EP-2496260-A1 ACTIVITY GENERATING DELIVERY MOLECULES Marina Biotech, Inc. (US) 2012-09-12 — — EP disclosed
WO-2012032509-A2 CONJUGATES OF POLYUNSATURATED FATTY ACIDS AND AMINE-CONTAINING COMPOUNDS AND USES THEREOF MEDWELL LABORATORIES LTD. (IL) 2012-03-15 — — WO disclosed
EP-0780340-B1 Intercalates and exfoliates formed with functional monomeric organic compounds; composite materials containing same and methods of modifying rheology therewith AMCOL INTERNATIONAL CORP (US) 2002-03-20 — — EP disclosed
US-6242500-B1 Intercalates and exfoliates formed with long chain (C6+) or aromatic matrix polymer-compatible monomeric, oligomeric or polymeric intercalant compounds, and composite materials containing same AMCOL INTERNATIONAL CORPORATION 2001-06-05 — — US disclosed
EP-0846662-A2 Intercalates and exfoliates, their process of manufacture and composites containing them AMCOL INTERNATIONAL CORPORATION (US) 1998-06-10 — — EP disclosed
EP-0846661-A2 Intercalates formed by co-intercalation of monomer, oligomer or polymer intercalants and surface modifier intercalants and layered materials and nanocomposites prepared with the intercalates AMCOL INTERNATIONAL CORPORATION (US) 1998-06-10 — — EP disclosed
EP-0846660-A2 Intercalates and exfoliates formed with long chain monomeric organic intercalant compounds having at least ten carbon atoms and composite materials containing same AMCOL INTERNATIONAL CORPORATION (US) 1998-06-10 — — EP disclosed
US-4177184-A SELECTIVELY HYDROGENATED MONOALKENYL ARENE-DIENE MULTI-BLOCK COPOLNG POLYMER SHELL OIL COMPANY (US) 1979-12-04 — — US disclosed
Send feedback